Elizabeth Johnson, PhD joined the Acumen team in January 2023 as a bioanalytical scientist. She has extensive background working with amyloid beta oligomers and has expertise in conducting immunofluorescent and biochemical assays to study the effects of amyloid beta oligomers in Alzheimer’s disease models. Prior to joining Acumen, Elizabeth completed a PhD in chemistry from Northwestern University in Evanston, IL. During her graduate studies, she conducted interdisciplinary work at the interface of chemistry and biology in the labs of Richard Silverman and Bill Klein and authored a dissertation on the effects of small molecules on amyloid beta oligomer-induced dysfunction in primary hippocampal neurons.